Elekta, Stockholm’s County Council and New Karolinska Solna have signed a 13-year collaboration agreement which focuses on innovation, joint research, and education and training within advanced radiation therapy.

The aim of the agreement is to bring significant improvements in access, quality of care and clinical outcomes for patients suffering from cancer. As part of the agreement Elekta will equip the cancer center and radiation therapy departments of New Karolinska Solna and Södersjukhuset (Stockholm South General Hospital).

“We look very much forward to collaborating closely with Karolinska and Södersjukhuset. NKS and Elekta both have the ambition to address the Stockholm region’s quality and capacity challenges in cancer care and to support the advancement and research in radiation therapy. This collaboration agreement will impact and improve the lives of thousands of patients,” said Richard Hausmann, Elekta’s President and CEO.

Stockholm County Council will order advanced linear accelerators, brachytherapy afterloaders and Elekta’s suite of software solutions. The project will also include a long-term service and support agreement.

This agreement is the final confirmation of the public tender, which Elekta originally announced on May 25, 2016. The initial order value is approximately SEK 350 million, excluding additional options for equipment and services over the 13-year lifetime of the agreement. SEK 198 million of the order value will be booked during the third quarter of Elekta’s fiscal year.